Literature DB >> 9917187

Management of dysplasia in ulcerative colitis: is prophylactic colectomy the preferred strategy?

T Axon1.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9917187     DOI： 10.1016/s1091-255x(98)80070-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  8 in total

Review 1.  Cancer surveillance in ulcerative colitis--a time for reappraisal.

Authors:  A T Axon
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

2.  Colorectal cancer risk and mortality in patients with ulcerative colitis.

Authors:  E Langholz; P Munkholm; M Davidsen; V Binder
Journal:  Gastroenterology       Date:  1992-11       Impact factor: 22.682

3.  Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis.

Authors:  D Provenzale; K V Kowdley; S Arora; J B Wong
Journal:  Gastroenterology       Date:  1995-10       Impact factor: 22.682

4.  Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis.

Authors:  P M Choi; F W Nugent; D J Schoetz; M L Silverman; R C Haggitt
Journal:  Gastroenterology       Date:  1993-08       Impact factor: 22.682

5.  Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.

Authors:  W R Connell; J E Lennard-Jones; C B Williams; I C Talbot; A B Price; K H Wilkinson
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

Review 6.  Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?

Authors:  C N Bernstein; F Shanahan; W M Weinstein
Journal:  Lancet       Date:  1994-01-08       Impact factor: 79.321

7.  Quality of life after restorative proctocolectomy with a pelvic ileal reservoir compares favorably with that of patients with medically treated colitis.

Authors:  P M Sagar; W Lewis; P J Holdsworth; D Johnston; C Mitchell; J MacFie
Journal:  Dis Colon Rectum       Date:  1993-06       Impact factor: 4.585

8.  Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program.

Authors:  B A Lashner; M D Silverstein; S B Hanauer
Journal:  Dig Dis Sci       Date:  1989-10       Impact factor: 3.199
  8 in total
  1 in total

Review 1.  The management of dysplasia associated with ulcerative colitis: colectomy versus continued surveillance.

Authors:  Martin S Friedlich; Maha Guindi; Hartley S Stern
Journal:  Can J Surg       Date:  2004-06       Impact factor: 2.089
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.